Skip to content
neratinib

Structure via PubChem · Public domain (PubChem)

EntityQ6995920· pop 15· linked from 494 articles

Also known as HKI 272, HKI-272

Neratinib (INN), sold under the brand name Nerlynx, is a tyrosine kinase inhibitor anti-cancer medication used for the treatment of breast cancer.

Chemical data

Formula
C30H29ClN6O3
Molecular weight
557 g/mol
IUPAC name
(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
SMILES
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C
InChIKey
JWNPDZNEKVCWMY-VQHVLOKHSA-N
XLogP
4.9
Polar surface area
112 Ų
H-bond donors
2
H-bond acceptors
8
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2017
Admin. routes
oral
Indications
breast neoplasm, breast carcinoma, neoplasm, non-small cell lung carcinoma

via ChEMBL · EBI

Wikidata facts

Mass
556.198966
Has use
medication
Show 8 more facts
Commons category
Neratinib
chemical formula
C₃₀H₂₉ClN₆O₃
NCI Thesaurus ID
C49094
canonical SMILES
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C
medical condition treated
breast cancer
physically interacts with
Erb-b2 receptor tyrosine kinase 2
isomeric SMILES
CCOc1cc2[nH]cc(C#N)c(=Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C
Sources (6)

via Wikidata · CC0

~5 min read

Encyclopedic overview

11 sections
Contents
  • Medical uses
  • Contraindications
  • Adverse effects
  • Interactions
  • Pharmacology
  • Cell biology
  • Chemistry
  • History
  • Brand names
  • References
  • External links

Neratinib (INN), sold under the brand name Nerlynx, is a tyrosine kinase inhibitor anti-cancer medication used for the treatment of breast cancer.

The most common side effect is diarrhea, which affects nearly all patients. Other common side effects include nausea (feeling sick), vomiting, tiredness, belly pain, rash, decreased appetite, stomatitis (sore, inflamed mouth), and muscle spasms.

Excerpted from Wikipedia’s “neratinib” article, available under the CC BY-SA 4.0 licence.